Targeted Oncology18 小时
TiNivo-2 Study Shows Comparable Patient-Reported Outcomes in RCC
Kathryn Beckermann, MD, PhD, discusses the patient-reported outcomes for tivozanib plus nivolumab from the phase 3 TiNivo-2 ...
Cure Today19 小时
Personalized Medicine Makes Strides Across the GU Oncology Treatment Space
Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.